High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo. - Mundle ST; Hernandez H; Hamberger J; Catalan J; Zhou C; Stegalkina S; Tiffany A; Kleanthous H; Delagrave S; Anderson SF (PloS one, 2013)